2024

1. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort

   Schizophrenia Research, Vol. 266, pp. 237-248

2. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

   Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

3. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

   Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

4. Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study

   Circulation Research, Vol. 134, Núm. 4, pp. 411-424

5. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

   The Lancet Oncology, Vol. 25, Núm. 1, pp. 46-61

6. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

   The Lancet Oncology, Vol. 25, Núm. 1, pp. 29-45

7. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report

   Journal of clinical immunology, Vol. 44, Núm. 4, pp. 86

8. Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

   Nature Reviews Cardiology

9. Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal Stimulation Sites

   Biological Psychiatry, Vol. 96, Núm. 2, pp. 101-113

10. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

11. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

12. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions

    Heart Lung and Circulation, Vol. 33, Núm. 7, pp. 915-931

13. Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents

    Human Brain Mapping, Vol. 45, Núm. 11

14. Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

    Journal of Clinical Oncology, Vol. 42, Núm. 22, pp. 2702-2712

15. Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study

    Molecular Psychiatry, Vol. 29, Núm. 2, pp. 496-504

16. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

17. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776

18. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

19. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis

    The Lancet Psychiatry, Vol. 11, Núm. 1, pp. 36-46

20. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667